Similarly to MCL, CD5+ follicular lymphoma (FL) and CD5+ marginal zone lymphoma (MZL) have also been shown to be associated with worse outcomes compared to their CD5- counterparts. The gene discussed is CD5; the disease is mantle cell lymphoma.